By Marie In News, ResearchPosted 20 December 2018 News about Golodirsen, Skipping Exon 53 Sarepta Therapeutics completes submission of New Drug Application seeking approval of golodirsen in patients with DMD amenable to skipping exon 53 Press Release here Golodirsen has been studied [...]